Senesco Technologies, Inc. (OTCMKTS:SNTI) Continues Above 5 Cents
Senesco Technologies, Inc. (OTCMKTS:SNTI), the company touted as an underpriced biotech miracle, added a bit more to its levels on a second consecutive day of extremely high buying volumes. The ticker grew by more than 12% as investors poured in over $880,000, and reached $0.054. Although the trend is not clear, SNTI managed to add around 50% since the end days of July. 
So far, SNTI has not seen promotional emails, and the next few days will show if this drug producer inspires the confidence of investors like better-known names in the sector.
But beneath the luster of a possible trend is the reality of a very large amount of convertible debt changed into shares at the end of June, at par value of one cent. With increased activity, some of these shares may more easily find willing buyers, so there is incentive to realize gains by selling those insider holdings. 
Outside those stock deals, the company is quite burdened by its long development history, with:
- $1.5 million cash
- $6.8 million total assets
- $3.5 million total liabilities
- Still zero revenues
- $61 million net loss since inception
- $986,719 quarterly loss
The other hopes for this company include a buyout from a bigger pharmaceutical firm, which may be applied to other small cap biotechs, as well as a possible reverse split, to decrease the 194 million shares. But none of these events are expected beyond the level of speculation.
Another hot mover in the same sector, Anavex Life Sciences, Corp. (OTCMKTS:AVXL) is trading on moderate volumes and recently added a third to its value, nearing 70 cents. Just on Wednesday, AVXL gained more than 14%. Still, the ticker is coming out of quite a deep valley, and has shown potential to drop suddenly. AVLX currently stands at 68 cents.
And Arch Therapeutics, Inc. (OTCBB:ARTH) is an example of a medical company that burned out on too much promotion, a combination of emails and paper mailers. The ticker started off well above the dollar, climbed for a while, but retreated more than 50% to around 50 cents.
SNTI is certainly in a low spot, and the trend may continue, but be aware of sudden temporary setbacks. The stock has shown the possibility for double-digit percentage drops in a single day, so stay away unless you are very aware of your time horizon, and are ready to lose an investment in part or in whole.
